Suchergebnisse - "De Ryck, Iris"

PubPharm (5)

1

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa : a randomised, observer-blind, placebo-controlled, phase 2 trial

enthalten in: The Lancet. Infectious diseases | 2020

von Tapia, M. | Sow, S. | Ndiaye, B. | +48

CommentIn: Lancet Infect Dis. 2020 Jun;20(6):636-637. - PMID 32199495

2

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa : a randomised, observer-blind, placebo-controlled, phase 2 trial

enthalten in: The Lancet. Infectious diseases | 2020

von Tapia, M. | Sow, S. | Mbaye, K. | +45

CommentIn: Lancet Infect Dis. 2020 Jun;20(6):636-637. - PMID 32199495

3

Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine

enthalten in: Vaccine | 2019

von Van Damme, P. | Leroux-Roels, G. | Vandermeulen, C. | +6

4

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults : a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

enthalten in: The Lancet. Infectious diseases | 2016

von De Santis, O. | Audran, R. | Pothin, E. | +22

CommentIn: Lancet Infect Dis. 2016 Mar;16(3):267-8. - PMID 26725448

5

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo : a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

enthalten in: The Lancet. Infectious diseases | 2016

von Tapia, M. | Sow, S. | Lyke, K. | +31

CommentIn: Lancet Infect Dis. 2016 Jan;16(1):2-3. - PMID 26546547

1
[1]